Journal
HUMAN VACCINES & IMMUNOTHERAPEUTICS
Volume 13, Issue 8, Pages 1741-1750Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2017.1327107
Keywords
Antisense oligonucleotide; cancer; epithelial-mesenchymal transition; monoclonal antibody; transforming growth factor-
Categories
Funding
- Lcs Foundation
Ask authors/readers for more resources
Transforming growth factor- (TGF-) regulates cell growth and differentiation, apoptosis, cell motility, extracellular matrix production, angiogenesis, and cellular immunity. It has a paradoxical role in cancer. In the early stages it inhibits cellular transformation and prevents cancer progression. In later stages TGF- plays a key role in promoting tumor progression through mainly 3 mechanisms: facilitating epithelial to mesenchymal transition, stimulating angiogenesis and inducing immunosuppression. As a result of its opposing tumor promoting and tumor suppressive abilities, TGF- and its pathway has represented potential opportunities for drug development and several therapies targeting the TGF- pathway have been identified. This review focuses on identifying the mechanisms through which TGF- is involved in tumorigenesis and current therapeutics that are under development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available